Cabot Wealth Management Inc. Decreases Stock Position in Oracle Corporation $ORCL

Cabot Wealth Management Inc. cut its stake in Oracle Corporation (NYSE:ORCL) by 1.9% in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 18,579 shares of the enterprise software provider’s stock after selling 362 shares during the period. Cabot Wealth Management Inc.’s holdings in Oracle were worth $4,062,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of the stock. Brighton Jones LLC boosted its holdings in Oracle by 0.8% in the second quarter. Brighton Jones LLC now owns 78,618 shares of the enterprise software provider’s stock valued at $17,188,000 after purchasing an additional 649 shares during the period. Linden Thomas Advisory Services LLC boosted its holdings in Oracle by 4.2% in the second quarter. Linden Thomas Advisory Services LLC now owns 19,528 shares of the enterprise software provider’s stock valued at $4,269,000 after purchasing an additional 788 shares during the period. Graybill Wealth Management LTD. lifted its holdings in Oracle by 226.8% during the 2nd quarter. Graybill Wealth Management LTD. now owns 915 shares of the enterprise software provider’s stock worth $200,000 after buying an additional 635 shares during the last quarter. Leavell Investment Management Inc. lifted its holdings in Oracle by 4.6% during the 2nd quarter. Leavell Investment Management Inc. now owns 37,612 shares of the enterprise software provider’s stock worth $8,223,000 after buying an additional 1,641 shares during the last quarter. Finally, Burke & Herbert Bank & Trust Co. lifted its holdings in Oracle by 9.1% during the 2nd quarter. Burke & Herbert Bank & Trust Co. now owns 8,975 shares of the enterprise software provider’s stock worth $1,962,000 after buying an additional 750 shares during the last quarter. 42.44% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

A number of analysts have issued reports on the company. Melius Research lifted their price target on Oracle from $270.00 to $370.00 and gave the stock a “buy” rating in a report on Wednesday, September 10th. Rothschild & Co Redburn assumed coverage on Oracle in a report on Thursday, September 25th. They set a “sell” rating and a $175.00 price target for the company. Cowen reaffirmed a “buy” rating on shares of Oracle in a report on Friday, October 17th. UBS Group lifted their price target on Oracle from $360.00 to $380.00 and gave the stock a “buy” rating in a report on Friday, October 17th. Finally, Redburn Partners set a $175.00 price target on Oracle in a report on Thursday, September 25th. Three investment analysts have rated the stock with a Strong Buy rating, twenty-six have assigned a Buy rating, ten have given a Hold rating and two have issued a Sell rating to the company’s stock. According to MarketBeat, Oracle currently has an average rating of “Moderate Buy” and a consensus target price of $323.69.

Insider Transactions at Oracle

In related news, CEO Clayton M. Magouyrk sold 40,000 shares of the business’s stock in a transaction dated Tuesday, October 21st. The stock was sold at an average price of $276.64, for a total value of $11,065,600.00. Following the transaction, the chief executive officer owned 154,030 shares in the company, valued at $42,610,859.20. The trade was a 20.62% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, Director William G. Parrett sold 11,500 shares of the business’s stock in a transaction dated Friday, September 12th. The shares were sold at an average price of $306.00, for a total value of $3,519,000.00. Following the completion of the transaction, the director owned 17,764 shares in the company, valued at $5,435,784. This trade represents a 39.30% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 170,769 shares of company stock worth $50,297,667 over the last three months. 40.90% of the stock is currently owned by company insiders.

Oracle Stock Up 1.2%

ORCL opened at $283.45 on Friday. The business’s 50-day simple moving average is $274.59 and its 200-day simple moving average is $221.04. The company has a debt-to-equity ratio of 3.33, a quick ratio of 0.62 and a current ratio of 0.62. Oracle Corporation has a one year low of $118.86 and a one year high of $345.72. The stock has a market capitalization of $808.05 billion, a P/E ratio of 65.61, a price-to-earnings-growth ratio of 3.04 and a beta of 1.53.

Oracle (NYSE:ORCL) last posted its earnings results on Tuesday, September 9th. The enterprise software provider reported $1.47 EPS for the quarter, missing analysts’ consensus estimates of $1.48 by ($0.01). Oracle had a return on equity of 72.93% and a net margin of 21.08%.The firm had revenue of $14.93 billion for the quarter, compared to analyst estimates of $15.04 billion. During the same quarter last year, the firm posted $1.39 EPS. The firm’s revenue for the quarter was up 12.2% on a year-over-year basis. Oracle has set its Q2 2026 guidance at 1.270-1.310 EPS. Analysts anticipate that Oracle Corporation will post 5 EPS for the current year.

Oracle Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Thursday, October 23rd. Investors of record on Thursday, October 9th were given a $0.50 dividend. This represents a $2.00 annualized dividend and a yield of 0.7%. The ex-dividend date was Thursday, October 9th. Oracle’s payout ratio is 46.30%.

Oracle Profile

Oracle Corporation offers products and services that address enterprise information technology environments worldwide. Its Oracle cloud software as a service offering include various cloud software applications, including Oracle Fusion cloud enterprise resource planning (ERP), Oracle Fusion cloud enterprise performance management, Oracle Fusion cloud supply chain and manufacturing management, Oracle Fusion cloud human capital management, Oracle Cerner healthcare, Oracle Advertising, and NetSuite applications suite, as well as Oracle Fusion Sales, Service, and Marketing.